CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 57,500 shares at $16.21 ($932K) on 2016-08-16, disclosed to the SEC on 2016-08-18.
Open-market purchase of $932k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.21 | 3,460 | $56K | 6.0% |
| 2 | $16.21 | 3,530 | $57K | 6.1% |
| 3 | $16.21 | 12,840 | $208K | 22.3% |
| 4 | $16.21 | 18,620 | $302K | 32.4% |
| 5 | $16.21 | 19,050 | $309K | 33.1% |
| Total | $16.21 avg | 57,500 |
| $932K |
| 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |